TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODYMEDIATED REJECTION

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)10-10
Number of pages1
JournalTransplant International
Volume34
Publication statusPublished - Aug-2021

Cite this